Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2005
11/16/2005EP1492795B1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
11/16/2005EP1487472A4 Stabilization of hypoxia inducible factor (hif) alpha
11/16/2005EP1463823A4 Methods of increasing endogenous erythropoietin (epo)
11/16/2005EP1379516B1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1222191B1 Benzodiazepin derivatives, the production and use thereof
11/16/2005EP1222182B1 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
11/16/2005EP1218374B1 Pharmaceutically active sulfonamide derivatives
11/16/2005EP1114052B1 4-aminopyrrolopyrimidines as kinase inhibitors
11/16/2005EP0923370B1 Acetyl choline esterase inhibitors for treating and diagnosing sleep disordered breathing
11/16/2005EP0876395B1 Inhibitors of interleukin-1beta converting enzyme
11/16/2005CN1697836A Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists
11/16/2005CN1697830A 嘧啶衍生物 Pyrimidine derivatives
11/16/2005CN1697655A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/16/2005CN1697652A Adhesive patch containing tulobuterol
11/16/2005CN1227354C Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions
11/16/2005CN1227265C Antibodies to CCR5
11/16/2005CN1227261C Monocyclic compounds with four bifunctional residues having NK-2 antagonist action, its preparation, medicine compositions and uses
11/16/2005CN1227251C Carbamates derived from arylalkylamines
11/16/2005CN1227248C Imidazolidine derivatives, their preparation, and their use as antinflamatory agent
11/16/2005CN1227238C Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidiones as antibacterials
11/16/2005CN1227035C Conjugates and method for production thereof, and their use for transporting molecules via biological membranes
11/16/2005CN1227011C Method of treating adenosine depletion
11/15/2005US6965027 Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate
11/15/2005US6965018 Antibodies directed to B7-related polypeptide, BSL-2
11/15/2005US6964984 Preventing desensitization of receptors
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005US6964972 8-Azabicyclo(3,2,1)oct-2 ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005US6964966 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections
11/15/2005US6964965 Corticotropin releasing factor antagonists
11/15/2005US6964956 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization
11/10/2005WO2005106459A1 Method of determining ability of drug to bind to troponin i and test drug for the determination
11/10/2005WO2005105793A1 Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure
11/10/2005WO2005105743A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
11/10/2005WO2005105111A1 Artificial lung surfactant composition and method of using the same
11/10/2005US20050251289 Medicament dispenser
11/10/2005US20050250832 For increasing blood-brain barrier permeability
11/10/2005US20050250792 Substituted piperidine compounds useful as modulators of chemokine receptor activity
11/10/2005US20050250790 Novel sulfonic acid derivatives
11/10/2005US20050250760 1-[(Indol-3-yl)carbonyl]piperazine derivatives
11/10/2005US20050250730 Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
11/10/2005US20050250712 Single dose azithromycin
11/10/2005US20050250196 Recombinant microorganisms expressing an oligosaccharide receptor mimic
11/10/2005US20050249701 Il-7 Drug substance, composition, preparation and uses
11/10/2005US20050249674 aerosol composition comprising a propellant and a first particulate material comprising particles having a median aerodynamic diameter with the range 0.05 to 11 mu m, such as a medicament suitable for pulmonary inhalation, and a second particulate material comprising particles having a median volume
11/10/2005US20050247312 Medicament dispenser
11/10/2005DE202004016078U1 Solid dosage topical pharmaceutical composition, useful to treat inflammatory diseases of mouth and throat e.g. tonsillitis, laryngitis, pharyngitis, gingivitis and sore throat, comprises combination of viscous drug and a local anesthetic
11/10/2005DE202004016077U1 Topical composition (in solid dosage form), useful to treat inflammatory diseases of mouth and throat e.g. tonsillitis, laryngitis, pharyngitis and gingivitis, comprises combination of Lichen islandicus and a local anesthetic
11/10/2005DE102004019540A1 Composition, useful for treatment of e.g. inflammatory and obstructive respiratory complaint, sinus rhythm in heart in atrioventricular block and circulatory shock, comprises 6-hydroxy-4H-benzo1,4oxazin-3-one derivatives and other actives
11/10/2005CA2755954A1 Quaternary quinuclidine derivatives and their use as muscarinic receptor antagonists
11/10/2005CA2565024A1 Therapeutic agent for left ventricular diastolic dysfunction
11/10/2005CA2563454A1 Crth2 receptor antagonists
11/10/2005CA2560165A1 Solid pharmaceutical form comprising an ltb4 antagonist
11/09/2005EP1593678A1 Crystal of (23s)-1alpha-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1593379A2 Uses of PPAR-gamma agonists in neutrophil-induced diseases
11/09/2005EP1592671A1 N-substituted (benzoimidazole-2-yl) phenyl amines, method for their production, their use as a medicament or diagnostic agent and medicament containing said substances
11/09/2005EP1592669A2 Novel substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
11/09/2005EP1592666A1 2,3 -bipyridines derivatives as selective cox-2 inhibitors
11/09/2005EP1592656A2 Medicinal compounds
11/09/2005EP1592422A2 New pharmaceutical compositions based on anticholinergics and inhibitors of tnf alpha synthesis or action
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1456202B1 Benzothiazoles
11/09/2005EP1278729B1 Benzosuberonylpiperidine compounds as analgesics
11/09/2005EP1259514B9 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/09/2005EP1254118B1 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/09/2005EP1202974B1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP1131055B1 Treatment set containing lungsurfactant compositions
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP1089973B1 Amidino and guanidino azetidinone tryptase inhibitors
11/09/2005EP1075519B1 Inhibitors of nf-kb activation
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005EP0792162B1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694882A Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
11/09/2005CN1694879A Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
11/09/2005CN1694875A 5-aryltetrazole compounds and uses thereof
11/09/2005CN1694723A Vaccine
11/08/2005US6963012 2-amino-2-[4-(3-benzyloxyphenoxy)-2-chlorophenyl]propyl-1,3-propanediol for example; treating autoimmune diseases such as rheumatoid arthritis, transplant rejection, psoriasis, dermatitis
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6963000 Benzothiazole derivatives with activity as adenosine receptor ligands
11/08/2005US6962996 Inhibitors of p38
11/08/2005US6962993 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/08/2005US6962941 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis
11/08/2005US6962940 Controrlling concentration of tumor necrosis factor, phosphodiesterase inhibitor; controlling cell differentiation, proliferation; antiinflammatory agents; cardiovascular disorders
11/08/2005US6962937 Imidazolidine derivatives, their preparation and their use
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962933 cerebral hemorrhage/infarction, head trauma, spinal cord injury, brain edema, multiple sclerosis, Alzheimer's/Parkinson's disease, amyotrophic lateral sclerosis, diabetes, osteoporosis, Creutzfeldt-Jakob disease or virus infections
11/08/2005US6962923 Pyrazole compositions
11/08/2005US6962918 Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunction
11/08/2005US6962915 Antiinflammatory agents
11/08/2005US6962911 Treatment of impotence, sexual dysfunction in female, stable, unstable and variant angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis
11/03/2005WO2005103288A1 Screening method
11/03/2005WO2005103257A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2005102981A1 Novel compounds and medicinal use thereof
11/03/2005WO2005102344A1 Pharmaceutical composition
11/03/2005WO2005102319A2 Use of melatonin in preventing postoperative complications
1 ... 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 ... 878